Medtronic plc Financial Ratios — MDT Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Return on Common Equity (%)	19.89	21.42	18.87	15.64	7.19	9.3	17.91	13.03	18.29	17.61	12.71	17.13	12.39	12.09	15.07
Return on Assets (%)	10.54	11.39	10.24	8.42	3.7	3.43	4.04	3.25	5.11	5.31	3.92	5.48	4.13	4.06	5.13
Return on Capital (%)	13.8	14.49	13.09	10.96	5.2	6.52	9.11	6.98	11.58	- -	8.21	10.07	7.64	7.59	9.05
Return on Invested Capital (%)	14.88	13.88	13.67	13.14	5.75	5.6	6.24	4.07	7.74	- -	5.92	6.97	5.34	5.51	7.06
Gross Margin (%)	76.14	75.97	75.13	74.52	68.86	68.29	68.72	69.73	70.04	67.41	65.19	67.98	65.67	65.34	65.32
EBITDA Margin (%)	33.94	32.85	33.69	33.33	28.94	30.45	29.97	28.97	30.41	27.27	25.22	27.19	27.31	25.23	28.03
Operating Margin (%)	28.76	27.7	28.75	28.33	22.49	20.67	20.15	20.14	21.7	18.06	16.25	18.65	18.67	17.06	19.5
Incremental Operating Margin (%)	-281.9	3.4	70.69	11.57	-8.02	16.37	2.96	19.75	99.01	85.77	-27.16	64.56	16.99	-27.26	86.96
Pretax Margin (%)	23.63	25.61	25.62	21.79	17.21	15.04	15.49	18.95	17.01	14.02	12.93	17.41	17.18	14.95	16.78
Profit Margin (%)	19.96	22.35	20.9	18.02	13.2	12.27	13.56	10.36	15.16	16.56	11.97	15.9	12.03	11.36	13.9
Net Income to Common Margin (%)	19.96	22.35	20.9	18.02	13.2	12.27	13.56	10.36	15.16	16.56	11.97	15.9	12.03	11.36	13.9
Effective Tax Rate (%)	16.62	17.61	18.44	17.27	23.26	18.4	12.56	45.46	10.53	- -	6.8	8.27	29.46	23.42	16.63
Dvd Payout Ratio (%)	31.72	29.9	30.43	36.41	49.98	60.46	59.1	80.82	57.68	60	85.39	66.54	94.91	98.21	76.04
Sustainable Growth Rate (%)	13.58	15.01	13.13	9.94	3.59	3.68	7.33	2.5	7.74	7.04	1.86	5.73	0.63	0.22	3.61

Credit (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Total Debt	9,657	10,466	10,601	11,872	36,107	31,013	33,401	25,763	25,315	24,797	26,389	24,114	24,364	25,024	28,516
ST Debt	1,723	3,274	910	1,613	2,434	993	7,520	2,058	838	2,776	11	3,742	20	1,092	2,874
LT Debt	7,934	7,192	9,691	10,259	33,673	30,020	25,881	23,705	24,477	22,021	26,378	20,372	24,344	23,932	25,642
Total Debt/EBITDA	1.83	1.97	1.9	2.09	6.16	3.53	3.75	2.97	2.72	3.14	3.47	2.8	2.86	3.06	3.03
Net Debt/EBITDA	1.57	1.71	1.71	1.82	5.31	3.19	3.19	2.54	2.25	2.61	2.99	2.36	2.67	2.9	2.79
Total Debt/EBIT	2.17	2.33	2.22	2.46	7.92	5.2	5.58	4.27	3.82	4.75	5.39	4.08	4.18	4.53	4.36
Net Debt/EBIT	1.85	2.03	2	2.14	6.83	4.7	4.75	3.66	3.15	3.95	4.64	3.44	3.9	4.29	4.01
EBITDA to Interest Expense	11.7	15.23	14.4	14.96	8.8	6.33	8.14	7.57	6.43	7.22	8.21	15.58	13.41	11.36	12.9
EBITDA-CapEx/Interest Expense	10.48	13.8	13.23	13.91	7.95	5.58	6.99	6.64	5.65	6.11	6.75	13.1	11.11	9.15	10.35
EBIT to Interest Expense	9.91	12.85	12.29	12.71	6.84	4.3	5.47	5.27	4.59	4.78	5.29	10.68	9.17	7.68	8.97
Interest Expense	450	349	388	379	666	1,386	1,094	1,146	1,444	1,092	925	553	636	719	729
Common Equity/Total Assets	52.79	53.59	54.91	52.82	51	21.78	23.3	26.67	29.29	31.02	30.72	33.25	33.42	33.79	34.33
Long-Term Debt/Equity (%)	49.69	42.03	51.9	52.76	63.26	57.66	51.42	46.64	48.75	43.29	51.12	38.64	47.12	47.47	53.14
Long-Term Debt/Capital (%)	30.69	25.64	32.56	32.15	37.2	56.95	45.57	47.18	47.34	41.5	47.82	37.36	44.31	43.02	42.58
Long-Term Debt/Total Assets (%)	25.86	21.91	27.77	27.04	31.56	30.13	25.92	25.94	27.29	24.28	28.34	22.39	26.77	26.6	27.97
Total Debt/Equity (%)	60.48	61.16	56.78	61.06	67.83	59.57	66.36	50.69	50.42	48.74	51.14	45.74	47.16	49.63	59.09
Total Debt/Capital (%)	37.36	37.31	35.62	37.2	39.89	58.83	58.81	51.28	48.96	46.73	47.84	44.22	44.35	44.98	47.35
Total Debt/Total Assets (%)	31.48	31.89	30.38	31.29	33.84	31.12	33.45	28.19	28.22	27.34	28.35	26.5	26.79	27.81	31.1
Net Debt to Equity	51.61	53.26	51.04	53.06	58.46	53.79	56.44	43.42	41.64	40.51	44.04	38.58	44.05	46.96	54.38
Net Debt/Capital (%)	33.68	33.91	33.04	33.81	36.32	56.19	54.81	47.38	44.19	42.12	44.07	40.02	42.62	43.57	45.24
EBITDA	5,264	5,316	5,589	5,668	5,863	8,780	8,903	8,678	9,291	7,885	7,597	8,615	8,527	8,167	9,401
EBITDA-CapEx	4,716	4,817	5,132	5,272	5,292	7,734	7,649	7,610	8,157	6,672	6,242	7,247	7,068	6,580	7,542
Operating Income (Loss)	4,460	4,483	4,770	4,818	4,557	5,960	5,986	6,034	6,632	5,222	4,895	5,908	5,830	5,520	6,540

Liquidity (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Cash Ratio	0.51	1.58	2.82	2.56	2.12	1.76	0.96	1.11	1.16	1.06	1.27	0.85	0.88	0.74	0.7
Current Ratio	1.94	2.76	4.52	3.82	3.36	3.29	1.74	2.28	2.59	2.13	2.65	1.86	2.39	2.03	1.85
Quick Ratio	1.31	2.34	3.9	3.38	2.83	2.54	1.35	1.71	1.9	1.5	1.91	1.3	1.54	1.31	1.2
CFO/Avg Current Liab	0.76	0.84	1	1.04	0.67	0.64	0.64	0.38	0.76	0.77	0.66	0.7	0.56	0.68	0.6
Common Equity/Total Assets	52.79	53.59	54.91	52.82	51	21.78	23.3	26.67	29.29	31.02	30.72	33.25	33.42	33.79	34.33
Long-Term Debt/Equity (%)	49.69	42.03	51.9	52.76	63.26	57.66	51.42	46.64	48.75	43.29	51.12	38.64	47.12	47.47	53.14
Long-Term Debt/Capital (%)	30.69	25.64	32.56	32.15	37.2	56.95	45.57	47.18	47.34	41.5	47.82	37.36	44.31	43.02	42.58
Long-Term Debt/Total Assets (%)	25.86	21.91	27.77	27.04	31.56	30.13	25.92	25.94	27.29	24.28	28.34	22.39	26.77	26.6	27.97
Total Debt/Equity (%)	60.48	61.16	56.78	61.06	67.83	59.57	66.36	50.69	50.42	48.74	51.14	45.74	47.16	49.63	59.09
Total Debt/Capital (%)	37.36	37.31	35.62	37.2	39.89	58.83	58.81	51.28	48.96	46.73	47.84	44.22	44.35	44.98	47.35
Total Debt/Total Assets (%)	31.48	31.89	30.38	31.29	33.84	31.12	33.45	28.19	28.22	27.34	28.35	26.5	26.79	27.81	31.1
CFO/Total Liabilities	25.44	28.46	30.45	26.81	9.17	10.97	13.89	11.55	17.75	18.17	15.04	19.2	15.37	17.16	16.22
CFO/CapEx	6.83	8.96	10.81	12.52	8.58	4.99	5.49	4.39	6.18	5.96	4.61	5.37	4.14	4.28	3.79
Altman's Z-Score	4.99	4.9	5.22	5.09	4.53	4.56	3.89	4.91	5.43	5.1	5.64	5.25	4.97	4.59	4.44

Working Capital (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Accounts Receivable Turnover	4.37	4.28	4.4	4.51	4.54	5.4	5.33	5.17	5.01	5.32	5.96	5.75	5.41	5.34	5.31
Days Sales Outstanding	83.51	85.35	82.89	80.9	80.37	67.56	68.51	70.54	72.92	68.59	61.25	63.43	67.5	68.38	68.8
Inventory Turnover	2.39	2.27	2.35	2.52	2.43	2.64	2.73	2.62	2.5	2.36	2.45	2.27	2.16	2.13	2.18
Days Inventory Outstanding	152.91	160.44	155.34	144.76	150.07	138.46	133.74	139.22	146.16	154.58	148.71	160.63	168.71	171.01	167.77
Accounts Payable Turnover	8.39	7.68	6.48	6.11	6.84	5.51	5.61	5.85	5.21	5.01	5.15	4.77	4.62	4.39	4.89
Accounts Payable Turnover Days	43.51	47.53	56.31	59.76	53.34	66.18	65.04	62.41	70.05	72.8	70.84	76.54	79.08	83.09	74.57
Cash Conversion Cycle	192.9	198.27	181.92	165.91	177.1	139.84	137.22	147.36	149.02	150.37	139.11	147.51	157.13	156.3	161.99
Inventory to Cash Days	-69.4	-75.09	-72.45	-63.86	-69.7	-70.9	-65.23	-68.68	-73.24	-85.98	-87.46	-97.19	-101.21	-102.63	-98.97
Inventories	1,619	1,800	1,712	1,725	3,463	3,473	3,338	3,579	3,753	4,229	4,313	4,616	5,293	5,217	5,476
Raw Materials	338	337	290	282	686	732	669	676	705	747	796	864	1,063	907	953
Work In Process	261	288	248	247	509	499	458	496	572	608	611	682	789	642	744
Finished Goods	1,020	1,175	1,174	1,196	2,268	2,242	2,211	2,407	2,476	2,874	2,906	3,070	3,440	3,668	3,779
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	- -	- -

Enterprise Value (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Market Capitalization	44,981	40,259	47,581	58,944	81,560	111,570	114,573	108,712	119,574	130,893	176,074	140,093	120,945	106,535	108,967
- Cash & Cash Equivalents	1,382	1,172	919	1,403	4,843	2,876	4,967	3,669	4,393	4,140	3,593	3,714	1,543	1,284	2,218
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	122	102	121	135	174	171	182	206	232
+ Total Debt	9,657	10,466	10,601	11,872	36,107	31,013	33,401	25,763	25,315	24,797	26,389	24,114	24,364	25,024	28,516
Enterprise Value	52,210	41,375	47,052	56,575	98,187	129,949	134,388	123,350	135,162	144,877	191,820	153,805	137,532	123,760	128,750
Total Capital	25,849	28,052	29,764	31,912	90,521	52,717	56,793	50,244	51,706	53,064	55,157	54,535	54,938	55,633	60,224
Total Debt/Capital (%)	37.36	37.31	35.62	37.2	39.89	58.83	58.81	51.28	48.96	46.73	47.84	44.22	44.35	44.98	47.35
Total Debt / EV	0.18	0.25	0.23	0.21	0.37	0.24	0.25	0.21	0.19	0.17	0.14	0.16	0.18	0.2	0.22
EV/Sales	3.37	2.56	2.84	3.33	4.85	4.51	4.52	4.12	4.42	5.01	6.37	4.85	4.4	3.82	3.84
EV/EBITDA	9.92	7.78	8.42	9.98	16.75	14.8	15.09	14.21	14.55	18.37	25.25	17.85	16.13	15.15	13.7
EV/EBIT	11.71	9.23	9.86	11.74	21.55	21.8	22.45	20.44	20.38	27.74	39.19	26.03	23.59	22.42	19.69
EV/Cash Flow to Firm	12.68	8.7	8.95	10.73	18.14	20.47	17.15	23.23	16.29	16.99	27.01	19.58	21.2	16.87	16.83
EV/Free Cash Flow to Firm	11.19	7.87	8.23	9.98	16.41	17.57	14.78	19.34	14.33	14.87	22.68	16.68	17.31	13.87	13.54
Diluted Market Cap	45,161	40,488	47,964	59,620	82,565	112,860	115,611	109,634	120,560	131,908	177,266	141,032	121,218	106,735	109,332
Diluted Enterprise Value	53,436	49,782	57,646	70,089	113,829	140,997	144,167	131,830	141,603	152,700	200,236	161,603	144,221	130,681	135,862
EV per Share	48.46	39.26	46.16	56.46	89.63	92.19	97.46	90.92	100.39	108.06	142.63	114.57	103.42	93.21	100.15
TTM Sales	15,508	16,184	16,590	17,005	20,261	28,833	29,710	29,953	30,557	28,913	30,117	31,686	31,227	32,364	33,537
TTM EBITDA	5,264	5,316	5,589	5,668	5,863	8,780	8,903	8,678	9,291	7,885	7,597	8,615	8,527	8,167	9,401
TTM Operating Income	4,460	4,483	4,770	4,818	4,557	5,960	5,986	6,034	6,632	5,222	4,895	5,908	5,830	5,520	6,540
TTM Cash Flow to Firm	4,116	4,758	5,258	5,273	5,413	6,349	7,837	5,309	8,299	8,528	7,102	7,853	6,488	7,338	7,652
TTM Free Cash Flow to Firm	4,664	5,257	5,715	5,669	5,984	7,395	9,091	6,377	9,433	9,741	8,457	9,221	7,947	8,925	9,511

Multiples (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Price/Free Cash Flow	10.53	8.15	8.88	11.13	15.09	18.02	14.21	19.06	14.81	15.62	23.34	16.18	16.17	12.75	12.28
EV/EBIT	11.71	9.23	9.86	11.74	21.55	21.8	22.45	20.44	20.38	27.74	39.19	26.03	23.59	22.42	19.69
Enterprise Value	52,210	41,375	47,052	56,575	98,187	129,949	134,388	123,350	135,162	144,877	191,820	153,805	137,532	123,760	128,750
Low Price	30.8	30.18	35.67	46.26	58.25	55.54	69.35	76.41	78.29	72.13	87.68	98.38	75.77	68.84	75.96
EV/Sales	3.37	2.56	2.84	3.33	4.85	4.51	4.52	4.12	4.42	5.01	6.37	4.85	4.4	3.82	3.84
EV/EBITDA	9.92	7.78	8.42	9.98	16.75	14.8	15.09	14.21	14.55	18.37	25.25	17.85	16.13	15.15	13.7
Price/Earnings	14.53	11.13	13.72	19.23	30.49	31.53	28.44	35.02	25.82	27.33	48.83	27.8	32.18	28.98	23.37
Price/Earnings Average	12.92	10.77	12.39	18.18	28.16	29.96	27.89	36	26.27	29.04	40.37	31.41	30.56	29.84	23.64
Price/Earnings High	15.42	12.63	14.11	20.57	32.56	32.17	30.56	39.21	29.12	34.2	49.34	36.2	37.63	33.24	26.54
Price/Earnings Low	10.72	8.79	10.49	15.12	23.86	22.13	23.74	33.4	22.76	20.19	32.7	26.21	26.81	24.86	20.95
Price/Book Value	2.78	2.29	2.48	2.94	1.5	5.14	4.92	4.46	4.55	4.65	6.16	4.63	3.98	3.5	3.46
Price/Book Value Average	2.47	2.21	2.24	2.78	1.38	4.88	4.83	4.58	4.63	4.94	5.09	5.23	3.78	3.61	3.5
Price/Book Value High	2.95	2.6	2.55	3.15	1.6	5.24	5.29	4.99	5.13	5.82	6.22	6.03	4.65	4.02	3.93
Price/Book Value Low	2.05	1.81	1.9	2.31	1.17	3.61	4.11	4.25	4.01	3.44	4.12	4.37	3.32	3.01	3.1
Price/Tangible Book Value	12.08	8.88	8.39	8.98	-5.3	-6.83	-9.88	-10.41	-11.6	-16.3	-21.74	-41.52	-26.27	-28.1	-21.17
Price/Tangible Book Value Average	10.74	8.59	7.58	8.49	-4.89	-6.49	-9.69	-10.7	-11.81	-17.31	-17.98	-46.91	-24.94	-28.94	-21.4
Price/Tangible Book Value High	12.82	10.08	8.63	9.6	-5.65	-6.97	-10.62	-11.65	-13.08	-20.39	-21.97	-54.07	-30.71	-32.23	-24.04
Price/Tangible Book Value Low	8.91	7.02	6.41	7.06	-4.14	-4.79	-8.25	-9.93	-10.23	-12.04	-14.56	-39.14	-21.89	-24.11	-18.97
Price/Sales	2.9	2.49	2.87	3.47	4.03	3.87	3.86	3.63	3.91	4.53	5.85	4.42	3.87	3.29	3.25
Price/Sales Average	2.58	2.41	2.59	3.28	3.72	3.68	3.78	3.73	3.98	4.81	4.83	4.99	3.68	3.39	3.29
Price/Sales High	3.08	2.82	2.95	3.71	4.3	3.95	4.14	4.06	4.41	5.66	5.91	5.76	4.53	3.78	3.69
Price/Sales Low	2.14	1.97	2.19	2.73	3.15	2.72	3.22	3.46	3.45	3.34	3.92	4.17	3.23	2.82	2.91
Price/Cash Flow	12.02	9.01	9.63	11.89	16.64	21.38	16.65	23.21	17.06	18.09	28.22	19.07	20.03	15.7	15.47
Price/Cash Flow Average	10.69	8.71	8.69	11.24	15.37	20.32	16.33	23.85	17.36	19.22	23.33	21.54	19.01	16.16	15.64
Price/Cash Flow High	12.76	10.22	9.9	12.71	17.77	21.81	17.89	25.99	19.24	22.64	28.51	24.83	23.41	18	17.57
Price/Cash Flow Low	8.87	7.12	7.36	9.35	13.02	15	13.9	22.13	15.04	13.37	18.9	17.98	16.68	13.47	13.86
Price/Free Cash Flow Average	9.36	7.88	8.02	10.53	13.94	17.12	13.94	19.59	15.07	16.59	19.3	18.28	15.35	13.13	12.42
Price/Free Cash Flow High	11.18	9.24	9.13	11.91	16.11	18.38	15.27	21.34	16.7	19.54	23.59	21.07	18.9	14.62	13.95
Price/Free Cash Flow Low	7.77	6.44	6.79	8.76	11.8	12.64	11.86	18.18	13.05	11.54	15.63	15.26	13.47	10.94	11.01
EV/Sales Average	3.11	2.98	3.17	3.89	5.26	4.65	4.74	4.47	4.67	5.53	5.6	5.64	4.41	4.13	4.08
EV/Sales High	3.61	3.4	3.53	4.32	5.84	4.92	5.1	4.8	5.1	6.38	6.67	6.41	5.26	4.51	4.48
EV/Sales Low	2.67	2.54	2.78	3.34	4.69	3.69	4.18	4.2	4.14	4.06	4.68	4.82	3.96	3.56	3.7
EV/EBITDA Average	9.17	9.07	9.42	11.68	18.18	15.28	15.83	15.43	15.36	20.27	22.19	20.76	16.16	16.36	14.54
EV/EBITDA High	10.64	10.34	10.48	12.97	20.19	16.17	17.03	16.58	16.78	23.41	26.44	23.56	19.28	17.89	15.98
EV/EBITDA Low	7.88	7.73	8.24	10.03	16.22	12.12	13.95	14.5	13.61	14.9	18.55	17.72	14.51	14.12	13.21
EV/EBIT Average	10.82	10.76	11.03	13.74	23.39	22.51	23.54	22.2	21.52	30.61	34.43	30.27	23.64	24.21	20.91
EV/EBIT High	12.56	12.26	12.28	15.26	25.97	23.82	25.33	23.85	23.5	35.34	41.04	34.36	28.2	26.47	22.98
EV/EBIT Low	9.3	9.17	9.65	11.79	20.86	17.86	20.75	20.86	19.07	22.5	28.78	25.84	21.23	20.9	18.99
Last Price	41.75	38.2	46.68	58.82	74.45	79.15	83.09	80.13	88.81	97.63	130.92	104.36	90.95	80.24	84.76
High Price	44.31	43.33	47.98	62.9	79.5	80.74	89.27	89.72	100.15	122.15	132.3	135.89	106.33	92.02	96.25
Enterprise Value Average	48,272	48,239	52,631	66,201	106,604	134,143	140,910	133,927	142,718	159,849	168,551	178,837	137,833	133,649	136,721
Enterprise Value High	56,015	54,959	58,588	73,501	118,356	141,948	151,650	143,919	155,885	184,559	200,900	202,990	164,401	146,121	150,269
Enterprise Value Low	41,459	41,101	46,040	56,826	95,077	106,426	124,183	125,861	126,453	117,497	140,891	152,636	123,762	115,345	124,184

Shares Outstanding	1,070	1,037	1,016	999	1,422	1,399	1,369	1,354	1,341	1,341	1,345	1,331	1,331	1,311	1,282
Diluted Weighted Avg Shares	1,082	1,060	1,028	1,014	1,109	1,426	1,391	1,368	1,358	1,351	1,354	1,351	1,333	1,330	1,290
Basic Weighted Avg Shares	1,077	1,054	1,019	1,002	1,096	1,410	1,379	1,357	1,346	1,341	1,345	1,342	1,330	1,328	1,286
Revenue per Share	14.39	15.36	16.28	16.97	18.49	20.45	21.55	22.08	22.7	21.57	22.39	23.6	23.48	24.38	26.09
EBITDA per Share	4.89	5.04	5.48	5.66	5.35	6.23	6.46	6.4	6.9	5.88	5.65	6.42	6.41	6.15	7.31
Operating Income per Share	4.14	4.25	4.68	4.81	4.16	4.23	4.34	4.45	4.93	3.89	3.64	4.4	4.38	4.16	5.09
Basic EPS, GAAP	2.87	3.43	3.4	3.06	2.44	2.51	2.92	2.29	3.44	3.57	2.68	3.75	2.83	2.77	3.63
Basic EPS from Cont Ops	2.84	3.24	3.4	3.06	2.44	2.51	2.92	2.28	3.45	3.58	2.7	3.77	2.85	2.79	3.65
Diluted EPS, GAAP	2.86	3.41	3.37	3.02	2.41	2.48	2.89	2.27	3.41	3.54	2.66	3.73	2.82	2.76	3.61
Diluted EPS from Cont Ops	2.82	3.22	3.37	3.02	2.41	2.48	2.89	2.26	3.43	3.56	2.68	3.75	2.84	2.79	3.64
Dividend per Share	0.9	0.97	1.04	1.11	1.22	1.52	1.72	1.84	2	2.16	2.32	2.52	2.72	2.76	2.79
Cash Flow per Share	3.47	4.24	4.85	4.95	4.47	3.7	4.99	3.45	5.2	5.4	4.64	5.47	4.54	5.11	5.48
Free Cash Flow per Basic Share	2.96	3.77	4.4	4.55	3.95	2.96	4.08	2.67	4.36	4.49	3.63	4.45	3.44	3.92	4.03
Cash & Equivalents per Share	2.25	8.87	10.92	14.21	17.78	8.96	9.94	8.28	7.31	8.17	8.04	7.88	5.99	6.03	6.97
Book Value per Share	15.03	16.69	18.8	20	49.67	15.4	16.88	17.97	19.51	20.98	21.26	22.53	22.85	22.9	24.48
Tangible Book Value per Share	3.46	4.3	5.56	6.55	-14.06	-11.59	-8.41	-7.7	-7.66	-5.99	-6.02	-2.51	-3.46	-2.86	-4

Medtronic plc

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)